Prof. Dr. Richard Chahwan, Paulina Wyrzykowska, Romina Fetti
Company Description
REMUUN is a University Zurich spin-off that has developed a modular platform designed to accelerate the discovery of precision antibodies, significantly improving immunotherapies for cancer and related diseases.